Human pathology最新文献

筛选
英文 中文
Prognostic significance and interobserver reproducibility of tumor budding and poorly differentiated clusters in primary duodenal adenocarcinoma. 原发性十二指肠腺癌中肿瘤出芽和低分化簇的预后意义和观察者间可重复性。
IF 3 2区 医学
Human pathology Pub Date : 2026-11-07 DOI: 10.1016/j.humpath.2026.106303
Shotaro Horonushi, Masashi Kudo, Yukiko Sasahara, Jun Ohara, Motokazu Sugimoto, Shin Kobayashi, Hiroto Katoh, Shingo Sakashita, Genichiro Ishii, Naoto Gotohda
{"title":"Prognostic significance and interobserver reproducibility of tumor budding and poorly differentiated clusters in primary duodenal adenocarcinoma.","authors":"Shotaro Horonushi, Masashi Kudo, Yukiko Sasahara, Jun Ohara, Motokazu Sugimoto, Shin Kobayashi, Hiroto Katoh, Shingo Sakashita, Genichiro Ishii, Naoto Gotohda","doi":"10.1016/j.humpath.2026.106303","DOIUrl":"10.1016/j.humpath.2026.106303","url":null,"abstract":"<p><p>Tumor budding and poorly differentiated clusters (PDCs) have been reported to have prognostic value in various malignancies. However, their relevance in primary duodenal adenocarcinoma remains unclear. This study evaluated the prognostic significance and interobserver agreement of tumor budding and PDCs in patients with pT1b or more advanced primary duodenal adenocarcinoma who underwent endoscopic or surgical resection between 2005 and 2023. Tumor budding and PDCs were assessed by three observers on hematoxylin and eosin-stained sections, classified as low (<5) or high (≥5), and designated as BD-low or BD-high and PDC-low or PDC-high, respectively. Among the 46 patients analyzed, the interobserver agreement was substantial for tumor budding (κ = 0.65, 95% confidence interval [CI] 0.47-0.82) and moderate for PDCs (κ = 0.48, 95% CI 0.27-0.65). BD-high and PDC-high were associated with adverse pathological features, including larger tumor size, advanced pathological T and N stages, and lymphatic permeation. BD-high was associated with lower recurrence-free survival (RFS; P = 0.013) and overall survival (OS; P = 0.004), whereas PDC-high was associated with lower RFS (P = 0.022) and OS (P = 0.045). Tumor budding and PDCs were associated with adverse pathological features and poorer survival outcomes, with acceptable interobserver reproducibility. Our findings support the clinical applicability of tumor budding and PDC assessment for pathological risk stratification in primary duodenal adenocarcinoma.</p>","PeriodicalId":13062,"journal":{"name":"Human pathology","volume":" ","pages":"106303"},"PeriodicalIF":3.0,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149370609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world HER2 testing practices and performance of HER2 immunohistochemistry in non-breast, non-gastroesophageal solid tumors: Experience at a large U.S. academic institution. 在非乳腺、非胃食管实体瘤中,真实世界HER2检测实践和HER2免疫组织化学的表现:美国一家大型学术机构的经验
IF 3 2区 医学
Human pathology Pub Date : 2026-11-07 DOI: 10.1016/j.humpath.2026.106304
Madhurya Ramineni, Hangchuan Shi, Brian S Finkelman, Jiqing Ye, Mark G Ettel, Bradley M Turner, Xi Wang, David G Hicks, Huina Zhang
{"title":"Real-world HER2 testing practices and performance of HER2 immunohistochemistry in non-breast, non-gastroesophageal solid tumors: Experience at a large U.S. academic institution.","authors":"Madhurya Ramineni, Hangchuan Shi, Brian S Finkelman, Jiqing Ye, Mark G Ettel, Bradley M Turner, Xi Wang, David G Hicks, Huina Zhang","doi":"10.1016/j.humpath.2026.106304","DOIUrl":"10.1016/j.humpath.2026.106304","url":null,"abstract":"<p><p>To better understand real-world practices on HER2 testing and guide practices for selecting patients for HER2-targeted therapy in non-breast/non-gastroesophageal (GE) solid tumors, we assessed 241 non-breast/non-GE solid tumors undergoing HER2 IHC at our institution between April 2024 and June 2025. Among 22 tumor types evaluated, endometrial (29.5%), colorectal (22.8%), and urothelial (10.4%) carcinomas were the most common. Among tumor types with ≥6 cases, urothelial carcinoma (UC) showed the highest HER2 positivity rate (32%, 8/25), while small bowel carcinoma had the highest HER2 alteration rate (50%, 3/6). Twenty-three HER2 positive tumors (9.5%) were identified, including 17 IHC 3+ (7.1%), five IHC 2+/FISH amplified and one IHC 2+/NGS amplified. The positive predictive value (PPV) of HER2 IHC using gastric criteria for ERBB2 amplification was 50% overall, 100% in non-UCs and 14.3% in UCs, respectively. Nine of 19 (47%) eligible patients received trastuzumab deruxtecan (T-DXd), and seven (78%) experienced stable disease or no radiologically detectable tumor during a median follow-up of 21 months. Fourteen cases (6.9%) were interpreted using criteria that did not align with the recommendations, and 51 (25.1%) lacked gastric criteria results for T-DXd eligibility. Our findings support continued education on HER2 testing and interpretation in non-breast/GE solid tumors to optimize selection for HER2-targeted therapy. HER2 alterations across 10 tumor types suggest therapeutic opportunities, whereas the low prevalence of HER2 positivity in other tumor types underscores further evaluation of the utility of routine upfront HER2 IHC. Additionally, the lower PPV of HER2 IHC for ERBB2 amplification in UCs warrants further investigation.</p>","PeriodicalId":13062,"journal":{"name":"Human pathology","volume":" ","pages":"106304"},"PeriodicalIF":3.0,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149370618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unusual morphologic variants of solitary fibrous tumor: A case series of 17 cases featuring 10 distinct histomorphologies. 孤立性纤维性肿瘤的异常形态变异:17例具有10种不同组织形态的病例系列。
IF 3 2区 医学
Human pathology Pub Date : 2026-11-07 DOI: 10.1016/j.humpath.2026.106299
Ahmed Shah, Jorge Torres-Mora, Ganesh Pandurang Pujari, Lori Erickson, Kevin Halling, Judith Thangaiah Jebastin
{"title":"Unusual morphologic variants of solitary fibrous tumor: A case series of 17 cases featuring 10 distinct histomorphologies.","authors":"Ahmed Shah, Jorge Torres-Mora, Ganesh Pandurang Pujari, Lori Erickson, Kevin Halling, Judith Thangaiah Jebastin","doi":"10.1016/j.humpath.2026.106299","DOIUrl":"10.1016/j.humpath.2026.106299","url":null,"abstract":"<p><strong>Background: </strong>Solitary fibrous tumors (SFTs) are mesenchymal neoplasms characterized by spindled-to-ovoid cells, fibrous stroma, prominent staghorn vasculature and harbor characteristic NAB2::STAT6 fusion. Although most SFTs are readily recognized histologically, some display unusual morphologic features that mimic other mesenchymal neoplasms and obscure the diagnosis.</p><p><strong>Methods: </strong>Following institutional review board approval, we identified 17 SFTs with unusual morphologic features from our institutional archives. Clinicopathologic features, immunohistochemistry, molecular findings, and Demicco risk stratification were reviewed. Molecular confirmation was available by RNA-based next-generation sequencing fusion panel.</p><p><strong>Results: </strong>The cohort included 17 tumors (9 males, 8 females). Sites included deep soft tissue of pelvis (n = 3), thigh (2), abdominal wall (1), dermis of temple (1), sinonasal tract (2) and visceral sites including liver (n = 3), lung (n = 2), brain (1), thyroid (1), and stomach (1). Median tumor size was 6 cm (range 3.5-15 cm). Histologic patterns included angiosarcoma-like (n = 2), pleomorphic liposarcoma-like (n = 2), osteosarcoma-like (n = 2) with one showing true heterologous osteosarcomatous differentiation, GLI1-altered neoplasm-like (n = 3), conventional small round cell morphology (n = 4) including one with Ewing-sarcoma-like immunophenotype, pseudoglandular (n = 1), low-grade fibromyxoid sarcoma-like (n = 1), soft tissue angiofibroma-like (n = 1), and sinonasal glomangiopericytoma-like (n = 1). Five tumors were considered morphologically consistent with dedifferentiated SFT. All tumors retained at least focal conventional SFT morphology. STAT6 IHC was positive in 16/17 tumors; NAB2::STAT6 fusion was confirmed in all 11 cases tested.</p><p><strong>Conclusions: </strong>SFTs may display a wide range of histologic patterns mimicking other benign and malignant mesenchymal neoplasms. Awareness of these variants and integration of IHC and molecular studies are critical to avoid misdiagnosis.</p>","PeriodicalId":13062,"journal":{"name":"Human pathology","volume":" ","pages":"106299"},"PeriodicalIF":3.0,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149370619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do clinical and pathologic differences exist between hepatic cavernous hemangiomas diagnosed radiologically versus those biopsied due to unclear clinical diagnosis? 影像学诊断的肝海绵状血管瘤与因临床诊断不明确而活检的肝海绵状血管瘤存在临床和病理差异吗?
IF 3 2区 医学
Human pathology Pub Date : 2026-11-07 DOI: 10.1016/j.humpath.2026.106300
Eleanor Dyer, Saumya Gurbani, Raul S Gonzalez
{"title":"Do clinical and pathologic differences exist between hepatic cavernous hemangiomas diagnosed radiologically versus those biopsied due to unclear clinical diagnosis?","authors":"Eleanor Dyer, Saumya Gurbani, Raul S Gonzalez","doi":"10.1016/j.humpath.2026.106300","DOIUrl":"10.1016/j.humpath.2026.106300","url":null,"abstract":"<p><p>Hemangiomas are the most common benign vascular tumors of the liver, typically asymptomatic and incidentally identified on imaging. Biopsies are contraindicated due to risk of hemorrhage and low diagnostic yield. However, clinical and radiologic suspicion for hemangioma remains low in some instances, often leading to biopsy. This study compared clinical and pathologic features between hemangiomas not suspected clinically versus those with high clinical confidence in a diagnosis of hemangioma. We searched our departmental archives for hepatic hemangiomas in biopsy and resection specimens, then performed chart review of radiology reports/clinical notes to determine whether the clinical diagnosis was concordant (suspected hemangioma) or discordant (unsuspected hemangioma) with pathology results. Our final cohort of 121 cases included 47 unsuspected hemangiomas (usually biopsies) and 74 suspected hemangiomas (usually resections). Patients with unsuspected hemangiomas were older on average, had smaller tumors, and more commonly had a history of malignancy (all P < 0.0001). By morphology, unsuspected hemangiomas were more likely to demonstrate sclerosis (P = 0.001) and thick-walled blood vessels (P = 0.008), while suspected hemangiomas were more likely to show cavernous architecture (P = 0.001). While hepatic hemangiomas are common, they may be clinically unsuspected in older patients with smaller lesions (perhaps obscuring classic radiologic changes) and a clinical history of malignancy (likely skewing the differential toward metastatic disease). Samples from such unsuspected hemangiomas are more likely to show sclerosis and thick-walled vessels and less likely to show cavernous architecture compared to clinically diagnosed hemangiomas, which may be resected and more likely show classic histologic features.</p>","PeriodicalId":13062,"journal":{"name":"Human pathology","volume":" ","pages":"106300"},"PeriodicalIF":3.0,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149370606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fusion Partner Dependent Immunophenotype, Chromoanagenesis, and Prognosis in MEF2D-Rearranged B-Lymphoblastic Leukemia. mef2d重排b淋巴母细胞白血病的融合伴侣依赖免疫表型、发色和预后。
IF 3 2区 医学
Human pathology Pub Date : 2026-11-07 DOI: 10.1016/j.humpath.2026.106302
Van Tuong Nguyen, Lina Han, Beenu Thakral, Guilin Tang, Rashmi Kanagal-Shamanna, Franklin Fuda, Prasad Koduru, Rolando Garcia, M Cristina Magallanes Hoyos, Miguel Cantu, Jing Xu, Olga K Weinberg, Sharon Germans, Jesse M Jaso, Mingyi Chen, Weina Chen
{"title":"Fusion Partner Dependent Immunophenotype, Chromoanagenesis, and Prognosis in MEF2D-Rearranged B-Lymphoblastic Leukemia.","authors":"Van Tuong Nguyen, Lina Han, Beenu Thakral, Guilin Tang, Rashmi Kanagal-Shamanna, Franklin Fuda, Prasad Koduru, Rolando Garcia, M Cristina Magallanes Hoyos, Miguel Cantu, Jing Xu, Olga K Weinberg, Sharon Germans, Jesse M Jaso, Mingyi Chen, Weina Chen","doi":"10.1016/j.humpath.2026.106302","DOIUrl":"https://doi.org/10.1016/j.humpath.2026.106302","url":null,"abstract":"<p><strong>Background: </strong>MEF2D-rearranged B-lymphoblastic leukemia/lymphoma (B-ALL) is a rare, recently recognized genetic entity with intermediate-to-poor risk. Its clinicopathologic and genomic features, especially differences among fusion partners, are incompletely characterized.</p><p><strong>Methods: </strong>We performed an integrated clinicopathologic, cytogenetic, optical genome mapping (OGM), and molecular analysis of 12 MEF2D-rearranged B-ALL patients, comprising nine MEF2D::BCL9 and three non-BCL9 fusions (CSF1R, DAZAP1, FOXJ2).</p><p><strong>Results: </strong>Median age was 14 years, and 92% of patients were female. All MEF2D::BCL9 fusions were cytogenetically cryptic, whereas non-BCL9 fusions were detectable by karyotyping. CD5 positivity (56%), CD5/CD10 co-expression (33%), and mature immunophenotype (11%) occurred only in MEF2D::BCL9 cases. Gene alterations were frequent, spanning cell-cycle regulation (50%), kinase signaling (25%), transcription factors (25%), and epigenetic/chromatin remodeling (17%) in the entire cohort. Chromoanagenesis was detected in 75% (3/4) of OGM-evaluated cases, including both MEF2D::BCL9 patients assessed. Despite 92% of patients achieving measurable residual disease negative remission after induction, relapse occurred in 27%, exclusively among MEF2D::BCL9 patients. MEF2D::BCL9 patients demonstrated a trend toward inferior overall survival compared with non-BCL9 patients (median OS, 18 months vs. not reached).</p><p><strong>Conclusions: </strong>MEF2D::BCL9-positive B-ALL may represent a distinct higher-risk subset of MEF2D-rearranged B-ALL, featured by cytogenetic crypticity, CD5 positivity, potentially frequent chromoanagenesis, and a trend toward inferior outcomes. CD5 expression in B-ALL should prompt molecular testing for MEF2D rearrangements. Larger multicenter studies are warranted to validate these findings.</p>","PeriodicalId":13062,"journal":{"name":"Human pathology","volume":" ","pages":"106302"},"PeriodicalIF":3.0,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149370607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinicopathologic characteristics of gastric adenocarcinoma in autoimmune gastritis: Impact of Helicobacter pylori infection and diagnostic implications of multifocal disease. 自身免疫性胃炎中胃腺癌的临床病理特征:幽门螺杆菌感染的影响和多灶性疾病的诊断意义。
IF 3 2区 医学
Human pathology Pub Date : 2026-11-07 DOI: 10.1016/j.humpath.2026.106301
JiLing Zeng, YuLu Feng, XiuYing Sun, Xia Chen, Chao Wang, Jing Xu
{"title":"Clinicopathologic characteristics of gastric adenocarcinoma in autoimmune gastritis: Impact of Helicobacter pylori infection and diagnostic implications of multifocal disease.","authors":"JiLing Zeng, YuLu Feng, XiuYing Sun, Xia Chen, Chao Wang, Jing Xu","doi":"10.1016/j.humpath.2026.106301","DOIUrl":"10.1016/j.humpath.2026.106301","url":null,"abstract":"<p><strong>Background: </strong>Autoimmune gastritis (AIG)-associated gastric adenocarcinoma (GC) and the impact of Helicobacter pylori (H. pylori) remain incompletely characterized, particularly regarding synchronous multifocal disease.</p><p><strong>Methods: </strong>We retrospectively reviewed 826 AIG patients from two centers and identified 93 with GC. Clinicopathological features and H. pylori association were analyzed. Five patients with synchronous multifocal adenocarcinoma (11 lesions) underwent detailed immunophenotypic and molecular profiling.</p><p><strong>Results: </strong>GC occurred in 11.26% of AIG patients. Tumors predominated in the gastric body (69.7%), were well-differentiated tubular adenocarcinomas (74.7%), and early-stage (90.5%). H. pylori infection was significantly more frequent in GC patients (16.1% vs. 5.2%; OR 3.52, 95% CI 1.88-6.70; P < 0.001). The neoplastic spectrum included multifocal intragastric carcinoma (5 cases), an AFP-producing carcinoma, fundic gland adenocarcinoma, and pyloric gland adenoma with intramucosal carcinoma. The five multifocal cases showed severe corpus atrophy; all 11 lesions were small (median 0.8 cm), flat, differentiated adenocarcinomas confined to mucosa/submucosa. Marked inter-lesional immunophenotypic heterogeneity (MUC2, MUC5AC, MUC6, p53) was observed. One of these cases showed a dMMR phenotype with MLH1/PMS2 loss across all three lesions. No recurrence occurred at median follow-up.</p><p><strong>Conclusions: </strong>AIG-associated GC shows distinctive body-predominant, well-differentiated, early-stage features. H. pylori infection is associated with a 3.5-fold increased GC risk in this cohort. Multifocal lesions display inter-lesional immunophenotypic heterogeneity consistent with field-related tumorigenesis. The finding of dMMR raises the differential diagnosis of Lynch syndrome and should prompt consideration of germline evaluation.</p>","PeriodicalId":13062,"journal":{"name":"Human pathology","volume":" ","pages":"106301"},"PeriodicalIF":3.0,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149370605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
p16 expression in genital chronic graft-versus-host disease: A potential diagnostic pitfall. p16在生殖器慢性移植物抗宿主病中的表达:一个潜在的诊断缺陷。
IF 3 2区 医学
Human pathology Pub Date : 2026-11-07 DOI: 10.1016/j.humpath.2026.106305
Mahsa Hajizadeh, Anne Mills, Ivan A Gonzalez, Mark Mochel, Sheila E Segura, Linglei Ma
{"title":"p16 expression in genital chronic graft-versus-host disease: A potential diagnostic pitfall.","authors":"Mahsa Hajizadeh, Anne Mills, Ivan A Gonzalez, Mark Mochel, Sheila E Segura, Linglei Ma","doi":"10.1016/j.humpath.2026.106305","DOIUrl":"10.1016/j.humpath.2026.106305","url":null,"abstract":"","PeriodicalId":13062,"journal":{"name":"Human pathology","volume":" ","pages":"106305"},"PeriodicalIF":3.0,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149370608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The evolving landscape of pathologic interpretation in metabolic dysfunction-associated steatotic liver disease 代谢功能障碍相关脂肪变性肝病病理解释的演变
IF 3 2区 医学
Human pathology Pub Date : 2026-11-01 Epub Date: 2026-04-01 DOI: 10.1016/j.humpath.2026.106112
Daniela S. Allende
{"title":"The evolving landscape of pathologic interpretation in metabolic dysfunction-associated steatotic liver disease","authors":"Daniela S. Allende","doi":"10.1016/j.humpath.2026.106112","DOIUrl":"10.1016/j.humpath.2026.106112","url":null,"abstract":"<div><div>Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide. This article discussed updates in diagnosis and emerging issues.</div><div>Key histologic findings include steatosis, lobular inflammation, and hepatocyte ballooning. Updated histologic guidance, with more detailed definitions, has recently been published for features in the histologic spectrum. Studies in portal changes seen in MASLD have shown the importance of this finding in relation to fibrosis and outcome.</div><div>Among the emerging issues, the importance of incidental findings and regression of fibrosis features is described. Digital pathology/machine learning algorithms, stain-free technologies, and molecular testing are being integrated into the diagnosis of MASLD, still mostly in the research setting but rapidly capturing the attention of the clinical community with the intent of aiding pathologists.</div></div>","PeriodicalId":13062,"journal":{"name":"Human pathology","volume":"177 ","pages":"Article 106112"},"PeriodicalIF":3.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147615999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuroendocrine cell proliferation in gastric and gastroesophageal carcinomas following neoadjuvant therapy: Frequency and association with clinicopathological parameters and prognosis 新辅助治疗后胃和胃食管癌的神经内分泌细胞增殖:频率及其与临床病理参数和预后的关系。
IF 3 2区 医学
Human pathology Pub Date : 2026-11-01 Epub Date: 2026-08-17 DOI: 10.1016/j.humpath.2026.106235
Serra Begum Emecen, Burcin Pehlivanoglu, Sulen Sarioglu, Anil Aysal, Zekai Serhan Derici, Koray Atila, Tugba Yavuzsen, Faruk Recep Ozalp, Barbaros Aydin, Ozgul Sagol
{"title":"Neuroendocrine cell proliferation in gastric and gastroesophageal carcinomas following neoadjuvant therapy: Frequency and association with clinicopathological parameters and prognosis","authors":"Serra Begum Emecen,&nbsp;Burcin Pehlivanoglu,&nbsp;Sulen Sarioglu,&nbsp;Anil Aysal,&nbsp;Zekai Serhan Derici,&nbsp;Koray Atila,&nbsp;Tugba Yavuzsen,&nbsp;Faruk Recep Ozalp,&nbsp;Barbaros Aydin,&nbsp;Ozgul Sagol","doi":"10.1016/j.humpath.2026.106235","DOIUrl":"10.1016/j.humpath.2026.106235","url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to determine the frequency of neuroendocrine cell proliferation (NCP) in the tumor bed and adjacent mucosa in gastric and gastroesophageal junction carcinomas that had received neoadjuvant therapy, and to elucidate its prognostic significance.</div></div><div><h3>Material and methods</h3><div>In 83 patients diagnosed with gastric or gastroesophageal junction adenocarcinoma who had received neoadjuvant therapy, the presence and the extent of NCP in the tumor bed and adjacent mucosa was examined and scored by chromogranin A immunohistochemistry and the association of this proliferation with other clinicopathological parameters was statistically analyzed.</div></div><div><h3>Results</h3><div>NCP was seen in the damaged, reparative or tumor-infiltrated mucosa in the tumor bed and the normal mucosa adjacent to the tumor in 46 cases (55.4%), as score 1 in 23 (27.7%), score 2 in 13 (15.7%) and score 3 in 10 (12%). This proliferation was not statistically associated with intestinal metaplasia (p = 0.683) and atrophy (p = 0.414). ypT stage was significantly correlated with NCP (p = 0.015) however there was no significant association between NCP and survival. No statistically significant association was found between the other clinicopathological parameters and NCP.</div></div><div><h3>Conclusion</h3><div>Non-neoplastic NCP both in the tumor bed and surrounding gastric mucosa is observed in a subset of cases following neoadjuvant therapy, and it does not appear to have any prognostic significance. However, further investigation is required to explore the cause of this proliferation.</div></div>","PeriodicalId":13062,"journal":{"name":"Human pathology","volume":"177 ","pages":"Article 106235"},"PeriodicalIF":3.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148792516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Histologic patterns of metastatic lymph nodes and recurrence patterns in resected pN1–2 lung adenocarcinoma pN1-2肺腺癌转移淋巴结的组织学特征及复发特征。
IF 3 2区 医学
Human pathology Pub Date : 2026-11-01 Epub Date: 2026-08-18 DOI: 10.1016/j.humpath.2026.106232
Masayoshi Watanabe, Tetsuro Taki, Shunta Tsuchida, Kotaro Nomura, Masataka Kawai, Masashi Wakabayashi, Yoichi Ohtaki, Tomohiro Miyoshi, Kenta Tane, Yuki Matsumura, Keiju Aokage, Yukiko Sasahara, Michiko Nagamine, Shingo Sakashita, Naoya Sakamoto, Keisuke Asakura, Masahiro Tsuboi, Genichiro Ishii
{"title":"Histologic patterns of metastatic lymph nodes and recurrence patterns in resected pN1–2 lung adenocarcinoma","authors":"Masayoshi Watanabe,&nbsp;Tetsuro Taki,&nbsp;Shunta Tsuchida,&nbsp;Kotaro Nomura,&nbsp;Masataka Kawai,&nbsp;Masashi Wakabayashi,&nbsp;Yoichi Ohtaki,&nbsp;Tomohiro Miyoshi,&nbsp;Kenta Tane,&nbsp;Yuki Matsumura,&nbsp;Keiju Aokage,&nbsp;Yukiko Sasahara,&nbsp;Michiko Nagamine,&nbsp;Shingo Sakashita,&nbsp;Naoya Sakamoto,&nbsp;Keisuke Asakura,&nbsp;Masahiro Tsuboi,&nbsp;Genichiro Ishii","doi":"10.1016/j.humpath.2026.106232","DOIUrl":"10.1016/j.humpath.2026.106232","url":null,"abstract":"<div><h3>Aims</h3><div>Histologic grading of the primary tumor (PT) is an established prognostic factor in lung adenocarcinoma; however, the clinical relevance of histologic patterns in metastatic lymph nodes (MLNs) remains unclear. This study investigated whether MLN histology is associated with recurrence patterns after complete resection.</div></div><div><h3>Methods</h3><div>We retrospectively analyzed 120 patients with pN1–2 lung adenocarcinoma who underwent complete resection at a single institution. Predominant histologic patterns of PTs and MLNs were categorized as low grade (lepidic), intermediate grade (papillary or acinar), or high grade (solid or micropapillary). Survival outcomes and recurrence patterns (locoregional vs distant) were compared across MLN histologic groups.</div></div><div><h3>Results</h3><div>Predominant histologic patterns were frequently discordant between PTs and MLNs (McNemar test, P = 0.01; κ = 0.25). High-grade PTs were associated with significantly shorter recurrence-free survival (RFS) than intermediate-grade tumors (P = 0.02), whereas MLN histology was not associated with RFS (P = 0.70). PT histology was not significantly related to recurrence site. In contrast, intermediate-grade MLNs showed a significantly higher incidence of locoregional recurrence than high-grade MLNs (P = 0.04), which was confirmed by cumulative incidence analysis (P = 0.02). Distant recurrence rates were comparable between the two groups (P = 0.39).</div></div><div><h3>Conclusions</h3><div>While histologic grading of the primary tumor reflects overall tumor aggressiveness and prognosis, the histologic architecture of metastatic lymph nodes may be associated with recurrence patterns rather than survival outcomes. These findings suggest that MLN morphology may provide complementary pathological information regarding patterns of locoregional recurrence after surgical resection.</div></div>","PeriodicalId":13062,"journal":{"name":"Human pathology","volume":"177 ","pages":"Article 106232"},"PeriodicalIF":3.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148792437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书